118 related articles for article (PubMed ID: 7015425)
1. A review of clinical studies of bestatin.
Oka S
Recent Results Cancer Res; 1980; 75():126-32. PubMed ID: 7015425
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies of bestatin on genitourinary cancer].
Ichikawa T; Hirokawa I; Ishihara Y
Jpn J Antibiot; 1985 Jan; 38(1):166-78. PubMed ID: 3989976
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effect of bleomycin combined with bestatin against Ehrlich ascites carcinoma in mice.
Kaya G; Akin C; Altuğ T; Devrim S
Proc Soc Exp Biol Med; 1988 Mar; 187(3):292-5. PubMed ID: 2450356
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinoma.
Blomgren H; Esposti PL; Näslund I; Johansen L; Lemming O
Acta Oncol; 1990; 29(6):809-12. PubMed ID: 2223154
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Kurita S; Ota K; Yamada K; Massaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2742-50. PubMed ID: 6508324
[TBL] [Abstract][Full Text] [Related]
6. Bestatin treatment and the peripheral lymphocyte population in cancer patients.
Blomgren H; Strender LE; Edsmyr F
Recent Results Cancer Res; 1980; 75():133-8. PubMed ID: 7232824
[TBL] [Abstract][Full Text] [Related]
7. [The immunomodulating action of bestatin in the combined therapy of bladder cancer patients].
Neprina GS; Panteleeva ES; Vatin OE; Kariakin OB
Urol Nefrol (Mosk); 1994; (2):34-8. PubMed ID: 8017004
[TBL] [Abstract][Full Text] [Related]
8. Screening of small molecular microbial products modulating immune responses and bestatin.
Umezawa H
Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
[TBL] [Abstract][Full Text] [Related]
9. Effect of bestatin on syngeneic tumors in mice.
Abe F; Shibuya K; Uchida M; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
Gan; 1984 Jan; 75(1):89-94. PubMed ID: 6586596
[TBL] [Abstract][Full Text] [Related]
10. Review of ubenimex (Bestatin): clinical research.
Ota K
Biomed Pharmacother; 1991; 45(2-3):55-60. PubMed ID: 1912370
[TBL] [Abstract][Full Text] [Related]
11. [Phase III study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma].
Ikeda S; Ishihara K; Taguchi G
Gan To Kagaku Ryoho; 1985 Jan; 12(1):77-85. PubMed ID: 3881086
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial.
Blomgren H; Näslund I; Esposti PL; Johansen L; Aaskoven O
Cancer Immunol Immunother; 1987; 25(1):41-6. PubMed ID: 3594491
[TBL] [Abstract][Full Text] [Related]
13. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
[TBL] [Abstract][Full Text] [Related]
14. [Phase I study of Bestatin: (I) A clinical study on determination of an optimal dose of Bestatin].
Saito K; Miyasato H; Tajima K; Ikeda S
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):211-7. PubMed ID: 6881973
[TBL] [Abstract][Full Text] [Related]
15. Effects of bestatin on the host immunity in patients treated for urogenital cancer.
Ozono S; Iwai A; Babaya K; Hiramatsu T; Yoshida K; Yamada K; Hirao Y; Aoyama H; Ohara S; Okajima E
Acta Oncol; 1990; 29(6):813-6. PubMed ID: 2223155
[TBL] [Abstract][Full Text] [Related]
16. [Phase III controlled studies of bestatin in malignant tumors of the skin--results of treatment of squamous cell carcinoma and genital Paget's disease].
Ikeda S; Ishihara K; Taguchi G
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1260-6. PubMed ID: 2988457
[TBL] [Abstract][Full Text] [Related]
17. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Cancer Immunol Immunother; 1986; 23(1):5-10. PubMed ID: 3533256
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulating properties of bestatin in cancer patients. A phase II trial.
Mathé G; Umezawa H; Misset JL; Brienza S; Canon C; Musset M; Reizenstein P
Biomed Pharmacother; 1986; 40(10):379-82. PubMed ID: 3495299
[TBL] [Abstract][Full Text] [Related]
20. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin].
Kumamoto Y; Tsukamoto T; Tamiya T; Takatsuka K; Furuya S; Yokoyama E; Honma A; Aoyama T; Tanda H; Kato S
Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
